News & Articles

Acquisition strengthens QIAGEN’s presence in the rapidly growing single-cell market

New EZ2 DNA Investigator Sep&Prep Kit automates sexual assault sample processing, improving sperm DNA recovery and separation from victim DNA

OGT brings clinical genomics experience to develop leading hybridization-based NGS technology delivering the insights clinical research laboratories need, every time

Partnership aims to broaden adoption of QIAcuityDx Four platform offering clinical diagnostic laboratories a range of clinical oncology assays

Two new partnerships enhance QIAGEN’s capabilities to support pharma partner clinical trials with significant expansion of MRD capabilities, especially using QIAcuity digital PCR

Partnership designed to expand QIAGEN’s leadership in oncology-focused digital PCR assays, advancing QIAcuity as the platform of choice for cancer research

The acquisition adds Franklin solution, an AI-powered cloud platform for clinical decision support in genetic diseases

New solutions support high-precision analytics for process development, batch release and regulatory compliance and enable a standardized workflow

QIAstat-Dx Respiratory Panel Mini targets the five most actionable respiratory pathogens in outpatient settings to help clinicians make precise treatment decisions

New agreement brings leaders in biomedical knowledge solutions and knowledge graph technologies together to aid the biopharmaceutical industry in analytics-driven drug discovery

QuantiFERON-TB Gold Plus remains crucial for the detection of latent tuberculosis infection, aiding in breaking the cycle of disease transmission

QIAcuityDx provides highly precise, absolute quantitation of target DNA and RNA, making it an ideal tool for monitoring cancer progression

QIAGEN and Eli Lilly collaboration set to launch the first commercially available IVD Kit for APOE genotyping

NeuMoDx CT/NG Assay, designed to improve accessibility, affordability and timeliness in sexually transmitted infection (STI) testing in the US

Accelerating DNA library pooling for high-quality next-generation sequencing results

QCI Interpret selected to support Denmark's whole-genome sequencing program

Discover enzymes and applications to catalyze your research success

The artus® SARS-CoV-2 Prep&Amp UM cuts PCR processing times by two thirds

The easy-to-use workflow can detect T-cell response early in the course of COVID-19 infection or following vaccination

The assays have shown efficacy against the newest variants of concern

Newly launched PAXgene Saliva Collector stabilizes collected sample to avoid preanalytical errors and thereby increases reproducibility and reliability of results

QIAreach SARS-CoV-2 Antigen Test, developed in collaboration with Ellume, provides accurate and objective results in 2 to 15 minutes